5 March 2024 - A new treatment option given with chemotherapy is recommended for some types of advanced or recurrent womb cancer in final draft NICE guidance published today.

540 adults will have access to Dostarlimab (Jemperli; GSK). Dostarlimab is a monoclonal antibody and helps the immune system to fight cancer. It is given through a drip over 30 minutes in hospital.

Read NICE press release